Research programme: acetamide analgesics - South Rampart Pharma
Alternative Names: Acetaminophen analogues - South Rampart PharmaLatest Information Update: 28 Aug 2024
At a glance
- Originator Louisiana State University
- Developer South Rampart Pharma
- Class Acetamides; Acetanilides; Aminophenols; Antipyretics; Non-opioid analgesics; Small molecules; Sulfonamides
- Mechanism of Action Cyclo-oxygenase 2 inhibitors; Cytochrome P-450 enzyme system inhibitors; Prostaglandin receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Preclinical Ocular pain; Pain; Postoperative pain
- No development reported Acute pain; Diabetic neuropathies; Fever; Neuropathic pain
Most Recent Events
- 28 Aug 2024 No recent reports of development identified for preclinical development in Acute pain in USA (IV)
- 28 Aug 2024 No recent reports of development identified for preclinical development in Diabetic-neuropathies in USA (PO)
- 28 Aug 2024 No recent reports of development identified for preclinical development in Fever in USA (IV)